Bleomycin Powder, For Solution
Product Images NDC 16714-886

5 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 16714-886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Formula (Ble05 0000 01)

Chemical Formula (Ble05 0000 01)
Chemical structure of Bleomycin shown as a detailed molecular diagram including atoms and bonds characteristic of this complex molecule.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Container Label (Ble05 0000 02 Ns V3)

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Container Label (Ble05 0000 02 Ns V3)
Label for Bleomycin for Injection, USP 15 units per vial, lyophilized powder for solution. Intended for intravenous, intramuscular, subcutaneous, or intrapleural use. Single-dose vial, cytotoxic agent. Manufactured for Northstar Rx LLC and by Kindos Pharmaceuticals Co., Ltd. in China. Storage instructions specify refrigeration between 2° and 8°C (36° and 46°F).*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Carton (Ble05 0000 04 Ns V4)

Principal Display Panel – Bleomycin For Injection, Usp 15 Units Per Vial Carton (Ble05 0000 04 Ns V4)
Packaging label for Bleomycin for Injection, USP, 15 units per vial, powder for solution. The label states it is a cytotoxic agent that must be diluted for intravenous, intramuscular, subcutaneous, or intrapleural use. Manufactured by Kindos Pharmaceuticals Co., Ltd in China for Northstar Rx LLC. The vial is single-dose and sterile, preservative-free, and stored refrigerated between 2° to 8°C. The label includes dosage warnings and barcode.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Container Label (Ble05 0000 03 Ns V3)

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Container Label (Ble05 0000 03 Ns V3)
Bleomycin for Injection, USP 30 units per vial powder for solution label. It states the drug must be diluted and is for intravenous, intramuscular, subcutaneous, or intrapleural use. The label includes storage instructions to keep dry powder refrigerated between 2° and 8°C, manufacturer details for Northstar Rx LLC, and notes the drug is sterile, nonpyrogenic, and preservative-free.*
FDA Label Image

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Carton (Ble05 0000 05 Ns V3)

Principal Display Panel – Bleomycin For Injection, Usp 30 Units Per Vial Carton (Ble05 0000 05 Ns V3)
Packaging label for Bleomycin injection USP, 30 units per vial, powder for solution. The label states it is for intravenous, intramuscular, subcutaneous, or intrapleural use and cautions that it is a cytotoxic agent. It is a single-dose vial manufactured for NorthStar Rx LLC and made by Kindos Pharmaceuticals Co., Ltd in China. Storage instructions and warnings about dilution and latex are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.